PMID- 38464358
OWN - NLM
STAT- PubMed-not-MEDLINE
LR  - 20240312
IS  - 2218-5836 (Print)
IS  - 2218-5836 (Electronic)
IS  - 2218-5836 (Linking)
VI  - 15
IP  - 2
DP  - 2024 Feb 18
TI  - High rate of clinically relevant improvement following anatomical total shoulder 
      arthroplasty for glenohumeral osteoarthritis.
PG  - 156-162
LID - 10.5312/wjo.v15.i2.156 [doi]
AB  - BACKGROUND: The minimal clinically important difference (MCID) is defined as the 
      smallest meaningful change in a health domain that a patient would identify as 
      important. Thus, an improvement that exceeds the MCID can be used to define a 
      successful treatment for the individual patient. AIM: To quantify the rate of 
      clinical improvement following anatomical total shoulder arthroplasty for 
      glenohumeral osteoarthritis. METHODS: Patients were treated with the Global Unite 
      total shoulder platform arthroplasty between March 2017 and February 2019 at 
      Herlev and Gentofte Hospital, Denmark. The patients were evaluated preoperatively 
      and 3 months, 6 months, 12 months, and 24 months postoperatively using the 
      Western Ontario Osteoarthritis of the Shoulder index (WOOS), Oxford Shoulder 
      Score (OSS) and Constant-Murley Score (CMS). The rate of clinically relevant 
      improvement was defined as the proportion of patients who had an improvement 24 
      months postoperatively that exceeded the MCID. Based on previous literature, MCID 
      for WOOS, OSS, and CMS were defined as 12.3, 4.3, and 12.8 respectively. RESULTS: 
      Forty-nine patients with a Global Unite total shoulder platform arthroplasty were 
      included for the final analysis. Mean age at the time of surgery was 66 years 
      (range 49.0-79.0, SD: 8.3) and 65% were women. One patient was revised within the 
      two years follow-up. The mean improvement from the preoperative assessment to the 
      two-year follow-up was 46.1 points [95% confidence interval (95%CI): 39.7-53.3, P 
      < 0.005] for WOOS, 18.2 points (95%CI: 15.5-21.0, P < 0.005) for OSS and 37.8 
      points (95%CI: 31.5-44.0, P < 0.005) for CMS. Two years postoperatively, 41 
      patients (87%) had an improvement in WOOS that exceeded the MCID, 45 patients 
      (94%) had an improvement in OSS that exceeded the MCID, and 42 patients (88%) had 
      an improvement in CMS that exceeded the MCID. CONCLUSION: Based on three 
      shoulder-specific outcome measures we find that approximately 90% of patients has 
      a clinically relevant improvement. This is a clear message when informing 
      patients about their prognosis.
CI  - (c)The Author(s) 2024. Published by Baishideng Publishing Group Inc. All rights 
      reserved.
FAU - Nyring, Marc Randall Kristensen
AU  - Nyring MRK
AD  - Section for Shoulder and Elbow Surgery, Department of Orthopaedic Surgery, Herlev 
      and Gentofte University Hospital, Hellerup 2900, Denmark. 
      marcrandallkristensen@gmail.com.
FAU - Olsen, Bo Sanderhoff
AU  - Olsen BS
AD  - Section for Shoulder and Elbow Surgery, Department of Orthopaedic Surgery, Herlev 
      and Gentofte University Hospital, Hellerup 2900, Denmark.
FAU - Amundsen, Alexander
AU  - Amundsen A
AD  - Section for Shoulder and Elbow Surgery, Department of Orthopaedic Surgery, Herlev 
      and Gentofte University Hospital, Hellerup 2900, Denmark.
FAU - Rasmussen, Jeppe Vejlgaard
AU  - Rasmussen JV
AD  - Section for Shoulder and Elbow Surgery, Department of Orthopaedic Surgery, Herlev 
      and Gentofte University Hospital, Hellerup 2900, Denmark.
LA  - eng
PT  - Journal Article
DEP - 20240218
PL  - United States
TA  - World J Orthop
JT  - World journal of orthopedics
JID - 101576349
PMC - PMC10921174
OTO - NOTNLM
OT  - Anatomical total shoulder arthroplasty
OT  - Clinically relevant improvement
OT  - Glenohumeral osteoarthritis
OT  - Minimal clinically important difference
OT  - Patient reported outcome measures
COIS- Conflict-of-interest statement: The authors Bo S Olsen, Alexander Amundsen, and 
      Jeppe V Rasmussen received institutional support for conducting the study 
      "Functional outcome and complications after Global Unite prostheses" which 
      provided data for the present study. In addition, Bo S Olsen and Jeppe V 
      Rasmussen are paid speakers for DePuy Synthes (Raynham, Massachusetts, United 
      States of America).
EDAT- 2024/03/11 06:44
MHDA- 2024/03/11 06:45
PMCR- 2024/02/18
CRDT- 2024/03/11 04:33
PHST- 2023/10/04 00:00 [received]
PHST- 2023/12/20 00:00 [revised]
PHST- 2024/01/08 00:00 [accepted]
PHST- 2024/03/11 06:45 [medline]
PHST- 2024/03/11 06:44 [pubmed]
PHST- 2024/03/11 04:33 [entrez]
PHST- 2024/02/18 00:00 [pmc-release]
AID - 10.5312/wjo.v15.i2.156 [doi]
PST - epublish
SO  - World J Orthop. 2024 Feb 18;15(2):156-162. doi: 10.5312/wjo.v15.i2.156. 
      eCollection 2024 Feb 18.